Your heart’s health might be secretly shaping your mind. That’s the unsettling message behind new research uncovering a surprising connection between coronary artery disease (CAD) and how well the brain functions. But here’s where things get interesting: even before symptoms appear, subtle brain changes may already be happening — and they could be warning signs of cognitive decline.
Individuals with CAD, a condition where blood vessels supplying the heart become narrowed or blocked, are already known to be at higher risk for strokes, dementia, and impaired cognitive performance. Yet, until now, scientists haven’t fully understood how exactly this heart condition influences the brain.
Peering into the brain’s wiring
A research team from Concordia University set out to explore this mystery. Their study, published in the Journal of Neuroscience (link), focused on how CAD impacts the brain’s white matter — the intricate network of nerve fibers that connects different brain regions and ensures smooth communication between them.
The researchers used an innovative multivariate analysis involving 12 separate white matter measurements. They compared MRI scans and cognitive test results from 43 people with CAD to those from 36 healthy participants, all over age 50. The goal: to find subtle patterns that single-metric studies might have missed.
Their findings were eye-opening. People with CAD displayed extensive structural differences in their brain’s white matter, particularly in areas nourished by the middle cerebral artery (MCA) and anterior cerebral artery. These regions are vital for cognitive abilities and motor control — and, as lead author and PhD researcher Zacharie Potvin-Jutras noted, they’re also among the most vulnerable to strokes.
“Our intention was to study the brain early in heart disease development,” Potvin-Jutras explained. “We specifically included participants with no prior stroke history to focus on the earliest, most subtle forms of brain change.”
When small details reveal the big picture
Traditional studies often examine one brain metric at a time, but Concordia’s multivariate approach combines them into a single comprehensive measure. This unified perspective captures complex health interactions that individual measures can’t. Even when changes in separate metrics appear minimal, their combined effect can reveal significant early signs of brain decline.
“Many of these metrics overlap and describe related processes,” said Claudine Gauthier, the study’s corresponding author and an associate professor in Concordia’s Department of Physics (link). “By integrating them into one metric, we can detect nuanced patterns of change and later dissect which white matter properties are driving those differences.”
Myelin — the brain’s insulation layer — tells the story
The data pointed to one primary culprit: reduced myelin content. Myelin acts like insulation around nerve fibers, speeding up the flow of electrical signals across the brain. When this protective covering erodes, communication slows — and that slowdown may be one of the earliest steps toward cognitive decline and aging.
Interestingly, individuals with stronger myelin integrity, particularly shown through a marker called R1, performed better on mental processing speed tests. That’s crucial, since processing speed strongly influences attention, problem-solving, and overall thinking ability. However, there weren’t yet clear gaps in total cognitive test scores between CAD patients and healthy individuals. This hints that the brain may show physical changes long before noticeable symptoms surface.
Why this matters — and what could come next
“This study gives us a clearer biological explanation of how heart disease can affect brain function,” Gauthier explained. “Now that we’ve identified myelin content as a key biomarker, we can begin to explore what interventions — like exercise, diet, or stress management — might help preserve myelin and protect cognition.”
The research was funded by the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Canada, and Brain Canada.
You can read the full publication: Multivariate White Matter Microstructure Alterations in Older Adults with Coronary Artery Disease (link).
But here’s the controversial question: If the brain shows signs of damage before cognitive problems even begin, should routine brain scans become part of early heart disease treatment? Or would that cross a medical line into overdiagnosis? Share your thoughts — does this discovery excite you or raise more concerns about what we might find before we’re ready?
